Doshi, Ushma A
Shaw, Jeremy
Fox, Todd E
Claxton, David F
Loughran, Thomas P
Kester, Mark
Article History
Received: 5 February 2017
Revised: 9 June 2017
Accepted: 16 August 2017
First Online: 27 October 2017
Competing interests
: MKāPenn State Research Foundation (PSRF) has licensed ceramide nanoliposomes to Keystone Nano, Inc. PSRF has previously licensed other ceramide nanotechnologies to Keystone Nano, Inc. MK is chief medical officer of Keystone Nano, Inc, State College, PA. The remaining authors declare no competing financial interests.